SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________
FORM 8-K
_____________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 1, 2003
BioSpecifics Technologies Corp.
(Exact Name of Registrant Specified in Charter)
Delaware
0-19879
11-3054851
(State or Other Jurisdiction
(Commission File
(I.R.S. Employer
of Incorporation)
Number)
Identification No.)
35 Wilbur Street
Lynbrook, New York 11563
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: (516) 593-7000
Item 5. Other Events and Regulation FD Disclosure.
On August 1, 2003, BioSpecifics Technologies Corp. issued a press release announcing notification by The Nasdaq Stock Market that the Nasdaq Listing Qualifications Panel has determined to conditionally continue the listing of the Company’s common stock on The Nasdaq SmallCap Market under the symbol BSTC. The text of the press release, which is attached as Exhibit 99.1, is incorporated by reference in its entirety.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
Exhibit No.
Description
99.1
Press release dated August 1, 2003
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BIOSPECIFICS TECHNOLOGIES CORP.
Date: August 4, 2003
By: /s/ Albert Horcher
Name:
Albert Horcher
Title:
Principal Accounting Officer
3
EXHIBIT INDEX
Exhibit No.
Description
99.1
Press release dated August 1, 2003
4